TORONTO, March 31, 2014 /CNW/ - The Leukemia & Lymphoma Society of Canada (LLSC) has named Shelagh Tippet-Fagyas as its new president, effective March 31, 2014.
Tippet-Fagyas will lead LLSC in its efforts to find cures and ensure access to therapies for all blood cancer patients in Canada. She will be working with the LLSC Board of Directors, reporting to Gilles Legault, Chair of the Board, of Montreal, Quebec.
"Shelagh has a proven track record of achievement in fund development, strategic planning, and building relationships with potential donors, internal and external stakeholders for national health charities," said Legault. "We look forward to the leadership skills she will contribute to LLSC, its Board of Directors, senior management and staff in her key role."
Most recently Tippet-Fagyas was a principal consultant for UrbanKinistics Consulting Group, where she consulted for more than 30 organizations in the social service, health, fitness and education sectors. She previously served as the national vice president, revenue development for The Arthritis Society. Her vast executive and senior management background also include experience with the Alzheimer Society of Ontario, the Make-A-Wish Foundation of Canada, Canadian MedicAlert Foundation and ParticipACTION.
Tippet-Fagyas earned her B.A. and Master's of Science in Applied Health from the University of Waterloo in Ontario. She is a graduate of the executive business development program, Richard Ivey School of Business, University of Western Ontario, in London, Ontario, and the executive marketing program, Queens University, Kingston, Ontario.
The Leukemia & Lymphoma Society of Canada (LLSC) is dedicated to finding cures and better treatments for blood cancers, as well as providing support for patients going through a cancer journey. Headquartered in Toronto, Ontario, there are five regional offices across the country based in Vancouver, Calgary, Toronto, Montreal and Halifax. The mission of The Leukemia & Lymphoma Society of Canada is to cure leukemia, lymphoma, Hodgkin's disease and myeloma and improve the quality of life of patients and their families, and is a registered charity in Canada. www.llscanada.org.
SOURCE: The Leukemia & Lymphoma Society of Canada